Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, September 1 2014 10:13pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Sunday, Aug 31, 2014
·Cipla Targets U.S. With Glaxo’s Advair, Anti-AIDS Drugs
at Bloomberg - Sun 6:00 pm ET
Friday, Aug 29, 2014
·Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Galectin Therapeutics, Inc. (GALT) To Contact The Firm
PR Newswire - Fri Aug 29
·Agile Therapeutics, Inc. (NASDAQ: AGRX) to Ring the NASDAQ Stock Market Closing Bell
GlobeNewswire - Fri Aug 29
Thursday, Aug 28, 2014
·UCB Files Patent Infringement Lawsuit vs. Actavis - Thu Aug 28
·Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
PR Newswire - Thu Aug 28
·SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT
PR Newswire - Thu Aug 28
·Leading Software Industry Executive, Andre Boisvert, Appointed Chairman of the Board of Directors of RES Software
Business Wire - Thu Aug 28
·Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
PR Newswire - Thu Aug 28
·Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA
GlobeNewswire - Thu Aug 28
·Mallinckrodt Pharmaceuticals to Present Data for Investigational and Approved Extended-Release Opioid Combination Medicines at PAINWeek
Business Wire - Thu Aug 28
·How Fibrocell Science (FCSC) Stock Stands Out in a Strong Industry - Thu Aug 28
·Why Catalyst Pharmaceutical (CPRX) Could Be Positioned for a Surge? - Thu Aug 28
Wednesday, Aug 27, 2014
·The Medicines Company to Present New Data from its Infectious Disease Portfolio at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Business Wire - Wed Aug 27
·Worth the Money? Assessing Executive Pay at Specialty Drug Makers
at The Wall Street Journal Online - Wed Aug 27
·Nature's Sunshine Announces Closing of Private Placement and Joint Venture Agreement With Fosun Pharma
GlobeNewswire - Wed Aug 27
·Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
Marketwire - Wed Aug 27
Tuesday, Aug 26, 2014
·Market-Caps and Stock Selection for Maximum Gains - Tue Aug 26
·Actavis to Present at Morgan Stanley Global Healthcare Conference 2014
PR Newswire - Tue Aug 26
·Deadline in Lawsuit for Investors in Galectin Therapeutics Inc. (GALT) Shares Over Alleged Securities Laws Violations Announced by Shareholders Foundation
GlobeNewswire - Tue Aug 26
·Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder
PR Newswire - Tue Aug 26
More Latest News...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
Clinical Trial Initiation
Accelerate clinical trial start-up, site selection, and recruitment.
ChainStoreGuide Newsroom
Get Industry News & Insights By Our Experienced Editorial Staff.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?